A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

NCT00717457 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1189

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus Type 2

Interventions

DRUG: exenatide
DRUG: taspoglutide
DRUG: taspoglutide

Sponsor

Hoffmann-La Roche